Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PRED

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE
Ezequiel Arranz-Martínez , Antonio Ruiz-García , Juan Carlos García Álvarez , Teresa Fernández Vicente , Nerea Iturmendi Martínez , Montserrat Rivera-Teijido , en representación del Grupo de Investigación del Estudio SIMETAP
{"title":"Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PRED","authors":"Ezequiel Arranz-Martínez ,&nbsp;Antonio Ruiz-García ,&nbsp;Juan Carlos García Álvarez ,&nbsp;Teresa Fernández Vicente ,&nbsp;Nerea Iturmendi Martínez ,&nbsp;Montserrat Rivera-Teijido ,&nbsp;en representación del Grupo de Investigación del Estudio SIMETAP","doi":"10.1016/j.arteri.2021.12.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Prediabetes is a major public health problem. The aims of the SIMETAP-PRED study were to determine the prevalence rates of prediabetes according to two diagnostic criteria, and to compare the association of cardiometabolic and renal risk factors between populations with and without prediabetes.</p></div><div><h3>Methods</h3><p>Cross-sectional observational study conducted in Primary Care. Based random sample: 6,588 study subjects (response rate: 66%). Two diagnostic criteria for prediabetes were used: 1) prediabetes according to the Spanish Diabetes Society (PRED-SDS): Fasting plasma glucose (FPG) 110–125<!--> <!-->mg/dL or HbA1c 6.0% –6.4%; 2) prediabetes according to the American Diabetes Association (PRED-ADA): FPG 100–125<!--> <!-->mg/dL or HbA1c 5.7%–6.4%. The crude and sex- and age-adjusted prevalence rates, and cardiometabolic and renal variables associated with prediabetes were assessed.</p></div><div><h3>Results</h3><p>The crude prevalence rates of PRED-SDS and PRED-ADA were 7.9% (95% <span>C</span>I 7.3–8.6%), and 22.0% (95% CI 21.0–23.0%) respectively, their age-adjusted prevalence rates were 6.6% and 19.1 respectively. The high or very high cardiovascular risk of the PRED-SDS or PRED-ADA populations were 68.6% (95%CI 64.5–72.6%) and 61.7% (95%CI 59.1–64.1%) respectively. Hypertension, hypertriglyceridemia, overweight, obesity, and increased waist-to-height ratio were independently associated with PRED-SDS. In addition to these factors, low glomerular filtration rate and hypercholesterolemia were also independently associated with PRED-ADA.</p></div><div><h3>Conclusions</h3><p>The prevalence of PRED-ADA triples that of PRED-SDS. Two thirds of the population with prediabetes had a high cardiovascular risk. Several cardiometabolic and renal risk factors were associated with prediabetes. Compared to the SDS criteria, the ADA criteria make the diagnosis of prediabetes easier.</p></div>","PeriodicalId":45230,"journal":{"name":"Clinica e Investigacion en Arteriosclerosis","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Arteriosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0214916821001650","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Prediabetes is a major public health problem. The aims of the SIMETAP-PRED study were to determine the prevalence rates of prediabetes according to two diagnostic criteria, and to compare the association of cardiometabolic and renal risk factors between populations with and without prediabetes.

Methods

Cross-sectional observational study conducted in Primary Care. Based random sample: 6,588 study subjects (response rate: 66%). Two diagnostic criteria for prediabetes were used: 1) prediabetes according to the Spanish Diabetes Society (PRED-SDS): Fasting plasma glucose (FPG) 110–125 mg/dL or HbA1c 6.0% –6.4%; 2) prediabetes according to the American Diabetes Association (PRED-ADA): FPG 100–125 mg/dL or HbA1c 5.7%–6.4%. The crude and sex- and age-adjusted prevalence rates, and cardiometabolic and renal variables associated with prediabetes were assessed.

Results

The crude prevalence rates of PRED-SDS and PRED-ADA were 7.9% (95% CI 7.3–8.6%), and 22.0% (95% CI 21.0–23.0%) respectively, their age-adjusted prevalence rates were 6.6% and 19.1 respectively. The high or very high cardiovascular risk of the PRED-SDS or PRED-ADA populations were 68.6% (95%CI 64.5–72.6%) and 61.7% (95%CI 59.1–64.1%) respectively. Hypertension, hypertriglyceridemia, overweight, obesity, and increased waist-to-height ratio were independently associated with PRED-SDS. In addition to these factors, low glomerular filtration rate and hypercholesterolemia were also independently associated with PRED-ADA.

Conclusions

The prevalence of PRED-ADA triples that of PRED-SDS. Two thirds of the population with prediabetes had a high cardiovascular risk. Several cardiometabolic and renal risk factors were associated with prediabetes. Compared to the SDS criteria, the ADA criteria make the diagnosis of prediabetes easier.

糖尿病前期的患病率及其与心脏代谢和肾脏因素的关系。研究SIMETAP-PRED
前驱糖尿病是一个重大的公共卫生问题。simtap - pred研究的目的是根据两种诊断标准确定前驱糖尿病的患病率,并比较有和没有前驱糖尿病的人群中心脏代谢和肾脏危险因素的相关性。方法在初级保健部门进行横断面观察研究。随机抽样:6588名研究对象(应答率66%)。采用两种前驱糖尿病诊断标准:1)根据西班牙糖尿病协会(PRED-SDS)的前驱糖尿病:空腹血糖(FPG) 110-125 mg/dL或HbA1c 6.0% -6.4%;2)根据美国糖尿病协会(PRED-ADA)的糖尿病前期:FPG 100-125 mg/dL或HbA1c 5.7%-6.4%。评估了与糖尿病前期相关的原始患病率、经性别和年龄调整的患病率以及心脏代谢和肾脏变量。结果PRED-SDS和PRED-ADA粗患病率分别为7.9% (95% CI 7.3 ~ 8.6%)和22.0% (95% CI 21.0 ~ 23.0%),年龄校正患病率分别为6.6%和19.1%。PRED-SDS或PRED-ADA人群的心血管风险高或极高分别为68.6% (95%CI 64.5-72.6%)和61.7% (95%CI 59.1-64.1%)。高血压、高甘油三酯血症、超重、肥胖和腰高比增加与PRED-SDS独立相关。除了这些因素外,低肾小球滤过率和高胆固醇血症也与PRED-ADA独立相关。结论PRED-ADA的患病率是PRED-SDS的三倍。三分之二的前驱糖尿病患者患心血管疾病的风险很高。一些心脏代谢和肾脏危险因素与前驱糖尿病有关。与SDS标准相比,ADA标准更容易诊断前驱糖尿病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinica e Investigacion en Arteriosclerosis
Clinica e Investigacion en Arteriosclerosis PERIPHERAL VASCULAR DISEASE-
CiteScore
3.20
自引率
6.20%
发文量
44
审稿时长
40 days
期刊介绍: La publicación idónea para acceder tanto a los últimos originales de investigación como a formación médica continuada sobre la arteriosclerosis y su etiología, epidemiología, fisiopatología, diagnóstico y tratamiento. Además, es la publicación oficial de la Sociedad Española de Arteriosclerosis.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信